Wilshire Completes Stock Deregistration
TM Capital advised Wilshire Enterprises, Inc. (OTC: WLSED.PK) in connection with its deregistration of its common stock
Fedders Acquires NYCOR, Inc.
TM Capital advised Fedders Corp. (NYSE) in its $48 million stock swap acquisition of NYCOR, Inc. (NASD)
Riverside Completes Debt-Equity Exchange
TM Capital advised the Riverside Group, Inc. (OTC) regarding an exchange of $13.9 million of indebtedness for an equity interest in Wickes Inc.
Teknowledge Adopts Rights Plan
TM Capital assisted the Board of Directors of Teknowledge, Inc. (NASDAQ) in adopting a shareholder’s rights plan.
Omega Completes Share Repurchase
TM Capital was retained by the Board of Directors of Omega Protein (NYSE) to act as financial advisor in connection with Omega’s $47.5 million share repurchase from Zapata Corporation (NYSE)
Immucor Board of Directors Re-Elected
TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected
Smurfit-Stone Modifies Plan of Reorganization
TM Capital acted as a financial advisor to the preferred equity holders of Smurfit-Stone in their successful legal challenge to the Company’s Plan of Reorganization to exit bankruptcy protection
Armstrong Pharma Acquired by Medeva
TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)
Immucor Goodwill Valuation Analysis
TM Capital provided Immucor, Inc. (NASDAQ) with an analysis of goodwill balances for potential impairment pursuant to FAS 142
SteriGenics Acquired by IBA
TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash